Atorvastatin Therapy in the Treatment of Dyslipidemia in Children With Steroid Sensitive Nephrotic Syndrome

Inclusion Criteria: * Children aged 8-18 years with known cases of steroid sensitive nephrotic syndrome * LDL ≥ 130 mg/dl in two consecutive serum fasting lipid profile, at least 4 weeks apart * while on remission * free of acute infection. Exclusion criteria * Children with previously diagnosed hyperlipidemia other than Nephrotic Syndrome. * Children with steroid resistant nephrotic syndrome * Children already on lipid lowering drugs * Secondary nephrotic syndrome. * Those parents/patients who refused to participate. 4\. Secondary nephrotic syndrome (SLE, amyloidosis etc.) 5. Nephrotic syndrome (initial episode). 6. Children taking Anti TB drug or anticonvulsant drugs. 7. Children having any active liver disease.